Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia

Annals of Neurology

Volumn 69, Issue 2, 2011, Pages 303-311

  Lancaster, Eric ^a   Huijbers, Maartje G M ^a   Bar, Vered ^b   Boronat, Anna ^a   Wong, Andrew ^a   Martinez Hernandez, Eugenia ^a   Wilson, Christina ^a   Jacobs, Dina ^a   Lai, Meizan ^a   Walker, Russell W ^c   Graus, Francesc ^d   Bataller, Luis ^e   Illa, Isabel ^f   Markx, Sander ^g   Strauss, Kevin A ^h,i,j   Peles, Elior ^b   Scherer, Steven S ^a   Dalmau, Josep ^a,k  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c BARROW NEUROLOGICAL INSTITUTE   (United States)

^d UNIVERSITY OF BARCELONA   (Spain)

^e HOSPITAL UNIVERSITARIO LA FE   (Spain)

^f UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^g College of Physicians and Surgeons ^*  (United States)

^h CLINIC FOR SPECIAL CHILDREN   (United States)

ⁱ FRANKLIN AND MARSHALL COLLEGE   (United States)

^j LANCASTER GENERAL HOSPITAL   (United States)

^k UNIVERSITY OF PENNSYLVANIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; AUTOANTIGEN; CONTACTIN ASSOCIATED PROTEIN LIKE 2; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

ADULT; AGED; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; ARTICLE; BRAIN TISSUE; CELL STRAIN HEK293; CLINICAL ARTICLE; CONTROLLED STUDY; ENCEPHALITIS; FEMALE; HUMAN; HUMAN CELL; IMMUNOADSORPTION; IMMUNOPRECIPITATION; MALE; MASS SPECTROMETRY; MOTOR NEURON DISEASE; MYASTHENIA GRAVIS; MYOKYMIA; NEUROPATHY; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SEIZURE;

AGED; ANIMALS; ANTIBODY SPECIFICITY; AUTOANTIBODIES; AUTOANTIGENS; ENCEPHALITIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; ISAACS SYNDROME; MALE; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MIDDLE AGED; NERVE TISSUE PROTEINS; PERIPHERAL NERVES;

EID: 79952528976     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22297     Document Type: Article

References (22)

1. Lai M, Huijbers MG, Lancaster E, et al. Investigation of Lgi1 as the antigen of limbic encephalitis previously attributed to potassium channels. Lancet Neurol 2010; 9: 776-785.
2. Buckley C, Oger J, Clover L, et al. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol 2001; 50: 73-78.
3. Tan KM, Lennon VA, Klein CJ, et al. Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology 2008; 70: 1883-1890. (Pubitemid 351684641)
4. Ances BM, Vitaliani R, Taylor RA, et al. Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain 2005; 128: 1764-1777. (Pubitemid 41373648)
5. Bushara KO, Goebel SU, Shill H, et al. Gluten sensitivity in sporadic and hereditary cerebellar ataxia. Ann Neurol 2001; 49: 540-543. (Pubitemid 32281342)
6. Strauss KA, Puffenberger EG, Huentelman MJ, et al. Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2. N Engl J Med 2006; 354: 1370-1377.
7. Poliak S, Salomon D, Elhanany H, et al. Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1. J Cell Biol 2003; 162: 1149-1160. (Pubitemid 37174196)
8. Brown AA, Xu T, Arroyo EJ, et al. Molecular organization of the nodal region is not altered in spontaneously diabetic BB-Wistar rats. J Neurosci Res 2001; 65: 139-149. (Pubitemid 32613756)
9. Poliak S, Gollan L, Martinez R, et al. Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channels. Neuron 1999; 24: 1037-1047. (Pubitemid 30017681)
10. Kleopa KA, Elman LB, Lang B, et al. Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestations. Brain 2006; 129: 1570-1584. (Pubitemid 43999388)
11. Diaz-Manera J, Rojas-Garcia R, Gallardo E, et al. Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome. Nat Clin Pract Neurol 2007; 3: 405-410. (Pubitemid 47040330)
12. Scherer SS, Arroyo EJ., Recent progress on the molecular organization of myelinated axons. J Peripher Nerv Syst 2002; 7: 1-12. (Pubitemid 34246033)
13. Bel C, Oguievetskaia K, Pitaval C, et al. Axonal targeting of Caspr2 in hippocampal neurons via selective somatodendritic endocytosis. J Cell Sci 2009; 122: 3403-3413.
14. Alarcon M, Abrahams BS, Stone JL, et al. Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am J Hum Genet 2008; 82: 150-159. (Pubitemid 351726082)
15. Friedman JI, Vrijenhoek T, Markx S, et al. CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Mol Psychiatry 2008; 13: 261-266. (Pubitemid 351272653)
16. Zweier C, de Jong EK, Zweier M, et al. CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila. Am J Hum Genet 2009; 85: 655-666.
17. Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 2010; 133: 2734-2748.
18. Fukata Y, Lovero KL, Iwanaga T, et al. Disruption of LGI1-linked synaptic complex causes abnormal synaptic transmission and epilepsy. Proc Natl Acad Sci U S A 2010; 107: 3799-3804.
19. Geschwind MD, Tan KM, Lennon VA, et al. Voltage-gated potassium channel autoimmunity mimicking Creutzfeldt-Jakob disease. Arch Neurol 2008; 65: 1341-1346.
20. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008; 7: 1091-1098.
21. Lai M, Hughes EG, Peng X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 2009; 65: 424-434.
22. Lancaster E, Lai M, Peng X, et al. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 2009; 9: 67-76.